Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 18:2014:363854.
doi: 10.1155/2014/363854. eCollection 2014.

Phagocytized neutrophil fragments in the bone marrow: a phenomenon most commonly associated with hodgkin lymphoma

Affiliations

Phagocytized neutrophil fragments in the bone marrow: a phenomenon most commonly associated with hodgkin lymphoma

Michael A Arnold et al. ISRN Hematol. .

Abstract

Bone marrow macrophages containing other cells, or large pieces of other cells, represent a distinctive feature of diseases such as Hemophagocytic Lymphohistiocytosis (HLH) and Rosai-Dorfman disease. We describe a distinct variation of phagocytic histiocyte morphology, featuring histiocytes containing predominantly fragments of neutrophil nuclei. We retrospectively reviewed initial bone marrow samples for Hodgkin lymphoma, Burkitt lymphoma, Ewing sarcoma, or evaluation for nonneoplastic conditions, scoring the presence or absence of the above-described histiocytes. We find that these histiocytes, which we term "fragmentophages," are associated with staging marrow sampling for malignancy, especially Hodgkin lymphoma (Hodgkin lymphoma: 28/34 or 82.4%, Ewing sarcoma: 11/26 or 42.3%, Burkitt lymphoma: 4/13 or 30.8%). These cells are significantly less common in marrow samples for nonneoplastic conditions (4/21 or 19.0%). Fragmentophages are significantly associated with malignancy, especially Hodgkin lymphoma, and their recognition has the potential to provide a clue to an underlying malignancy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Macrophages containing granulocyte nuclear debris. Macrophages containing granulocyte nuclear debris can be seen dispersed throughout marrow biopsies in H&E stained sections ((a) H&E 40x objective magnification, (b) H&E 100x oil objective magnification) and aspirate marrow smears ((c) Wright-Giemsa 100x oil). Immunohistochemical staining for myeloperoxidase highlights the phagocytosed cells ((d) 100x oil). H&E: Hematoxylin and Eosin.
Figure 2
Figure 2
Distinct histologic features of macrophages containing other cell types. Macrophages containing neutrophils, or “fragmentophages,” show cytoplasmic inclusion of cells with lobulated nuclei ((a) H&E 100x oil). In contrast, HLH features macrophages containing red blood cells ((b) Wright-Giemsa 100x oil) and Rosai-Dorfman with macrophages containing intact lymphocytes ((c) Wright-Giemsa 100x oil). Tingible body macrophages are distinguished by cytoplasm which contains a range of fragments, from whole lymphocytes to small debris ((d) Wright-Giemsa 100x oil).
Figure 3
Figure 3
Distribution of bone marrow macrophages containing neutrophils by underlying diagnosis.

Similar articles

Cited by

References

    1. Huang Q, Chang KL, Weiss LM. Extranodal Rosai-Dorfman disease involving the bone marrow: a case report. The American Journal of Surgical Pathology. 2006;30(9):1189–1192. - PubMed
    1. Risma K, Jordan MB. Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Current Opinion in Pediatrics. 2012;24(1):9–15. - PubMed
    1. Gaiolla RD, Domingues MAC, Niéro-Melo L, de Oliveira DE. Serum levels of interleukins 6, 10, and 13 before and after treatment of classic Hodgkin lymphoma. Archives of Pathology & Laboratory Medicine. 2011;135(4):483–489. - PubMed
    1. Kowalska M, Tajer J, Chechlinska M, et al. Discriminant analysis involving serum cytokine levels and prediction of the response to therapy of patients with Hodgkin lymphoma. Tumor Biology. 2012;33(5):1733–1738. - PubMed
    1. Jones K, Vari F, Keane C, et al. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clinical Cancer Research. 2013;19(3):731–742. - PubMed

LinkOut - more resources